GLP-1, or glucagon-like peptide-1, has emerged as a revolutionary player in the landscape of weight management, especially for individuals without diabetes. Traditionally associated with the treatment of type 2 diabetes, GLP-1’s role has expanded to address a critical aspect of modern health concerns: obesity and non-diabetic weight loss.